-
Je něco špatně v tomto záznamu ?
Quantification of oxidative stress markers in the blood sera following subacute administration of different oximes in rats
V. Jaćević, J. Grujić-Milanović, Z. Milovanović, L. Nežić, L. Amidžić, N. Vojinović, B. Marković, V. Dobričić, P. Milosavljević, E. Nepovimova, K. Kuča
Jazyk angličtina Země Irsko
Typ dokumentu časopisecké články
- MeSH
- antioxidancia metabolismus farmakologie MeSH
- biologické markery * krev MeSH
- glutathion * krev metabolismus MeSH
- katalasa metabolismus krev MeSH
- krysa rodu rattus MeSH
- malondialdehyd krev metabolismus MeSH
- oxidační stres * účinky léků MeSH
- oximy * farmakologie MeSH
- peroxidace lipidů účinky léků MeSH
- potkani Wistar * MeSH
- produkty pokročilé oxidace proteinů krev MeSH
- reaktivátory cholinesterasy farmakologie MeSH
- superoxiddismutasa metabolismus krev MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Oxidative stress status, as a disruption of redox homeostasis, in the blood sera of Wistar rats caused by repeated application of selected acetylcholinesterase reactivators - asoxime, obidoxime, K027, K048, K074, and K075 were evaluated. Throughout this study, each oxime in a dose of 0.1 of LD50/kg im was given 2x/week for 4 weeks. Then, seven days after the last oximes' application, markers of lipid peroxidation (malondialdehyde, MDA), and protein oxidation (advanced oxidation protein products, AOPP), as well as the activity of antioxidant enzymes (catalase, CAT, superoxide dismutase, SOD, reduced glutathione, GSH, and oxidized glutathione, GSSG), were determined. Oxidative stress parameters, MDA and AOPP were significantly highest in the K048-, K074- and K075-treated groups (p < 0.001). The activity of CAT was significantly elevated in the obidoxime-treated group (p < 0.05), while treatment with K027, K048, and K074 induced high elevation in SOD levels (p < 0.01, p < 0.001). Interestingly, the activity of GSH in each oxime-treated group was significantly elevated. Unlike, treatment with obidoxime caused elevation in GSSG levels (p < 0.01). As a continuation of our previously published data, these results assure that applied oximes following subacute treatment ameliorated the oxidative status and further adverse systemic toxic effects in rats.
Biomedical Research Center University Hospital Hradec Kralove 50005 Hradec Kralove Czech Republic
Special Police Unit Ministry of Interior Trebevićka 12 A 11 030 Belgrade Serbia
Veterinary Services Center Military Health Department Crnotravska 17 11040 Belgrade Serbia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019277
- 003
- CZ-PrNML
- 005
- 20241024111407.0
- 007
- ta
- 008
- 241015e20240709ie f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.cbi.2024.111138 $2 doi
- 035 __
- $a (PubMed)38992768
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Jaćević, Vesna $u Department for Experimental Toxicology and Pharmacology, National Poison Control Centre, Military Medical Academy, Crnotravska 17, 11040 Belgrade, Serbia; Medical Faculty of the Military Medical Academy, University of Defence, Crnotravska 17, 11040 Belgrade, Serbia; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03, Hradec Kralove, Czech Republic. Electronic address: v_jacevic@yahoo.com
- 245 10
- $a Quantification of oxidative stress markers in the blood sera following subacute administration of different oximes in rats / $c V. Jaćević, J. Grujić-Milanović, Z. Milovanović, L. Nežić, L. Amidžić, N. Vojinović, B. Marković, V. Dobričić, P. Milosavljević, E. Nepovimova, K. Kuča
- 520 9_
- $a Oxidative stress status, as a disruption of redox homeostasis, in the blood sera of Wistar rats caused by repeated application of selected acetylcholinesterase reactivators - asoxime, obidoxime, K027, K048, K074, and K075 were evaluated. Throughout this study, each oxime in a dose of 0.1 of LD50/kg im was given 2x/week for 4 weeks. Then, seven days after the last oximes' application, markers of lipid peroxidation (malondialdehyde, MDA), and protein oxidation (advanced oxidation protein products, AOPP), as well as the activity of antioxidant enzymes (catalase, CAT, superoxide dismutase, SOD, reduced glutathione, GSH, and oxidized glutathione, GSSG), were determined. Oxidative stress parameters, MDA and AOPP were significantly highest in the K048-, K074- and K075-treated groups (p < 0.001). The activity of CAT was significantly elevated in the obidoxime-treated group (p < 0.05), while treatment with K027, K048, and K074 induced high elevation in SOD levels (p < 0.01, p < 0.001). Interestingly, the activity of GSH in each oxime-treated group was significantly elevated. Unlike, treatment with obidoxime caused elevation in GSSG levels (p < 0.01). As a continuation of our previously published data, these results assure that applied oximes following subacute treatment ameliorated the oxidative status and further adverse systemic toxic effects in rats.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a oxidační stres $x účinky léků $7 D018384
- 650 12
- $a oximy $x farmakologie $7 D010091
- 650 12
- $a potkani Wistar $7 D017208
- 650 12
- $a biologické markery $x krev $7 D015415
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a glutathion $x krev $x metabolismus $7 D005978
- 650 _2
- $a superoxiddismutasa $x metabolismus $x krev $7 D013482
- 650 _2
- $a peroxidace lipidů $x účinky léků $7 D015227
- 650 _2
- $a katalasa $x metabolismus $x krev $7 D002374
- 650 _2
- $a malondialdehyd $x krev $x metabolismus $7 D008315
- 650 _2
- $a reaktivátory cholinesterasy $x farmakologie $7 D002801
- 650 _2
- $a produkty pokročilé oxidace proteinů $x krev $7 D062107
- 650 _2
- $a antioxidancia $x metabolismus $x farmakologie $7 D000975
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Grujić-Milanović, Jelica $u University of Belgrade - Institute for Medical Research, National Institute of the Republic of Serbia, Department for Cardiovascular Research, Dr Subotića 4, 11 132, Belgrade, Serbia
- 700 1_
- $a Milovanović, Zoran $u Special Police Unit, Ministry of Interior, Trebevićka 12/A, 11 030 Belgrade, Serbia
- 700 1_
- $a Nežić, Lana $u Department of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, Save Mrkalja 14, 78000 Banja Luka, Bosnia and Herzegovina
- 700 1_
- $a Amidžić, Ljiljana $u Centre for Biomedical Research, Faculty of Medicine, University of Banja Luka, Save Mrkalja 14, 78000 Banja Luka, Bosnia and Herzegovina; Department of Human Genetics, Faculty of Medicine, University of Banja Luka, Save Mrkalja 14, 78000, Banja Luka, Bosnia and Herzegovina
- 700 1_
- $a Vojinović, Nataša $u Department of Human Genetics, Faculty of Medicine, University of Banja Luka, Save Mrkalja 14, 78000, Banja Luka, Bosnia and Herzegovina
- 700 1_
- $a Marković, Bojan $u University of Belgrade - Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Vojvode Stepe 450, 11121, Belgrade, Serbia
- 700 1_
- $a Dobričić, Vladimir $u University of Belgrade - Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Vojvode Stepe 450, 11121, Belgrade, Serbia
- 700 1_
- $a Milosavljević, Petar $u Veterinary Services Center, Military Health Department, Crnotravska 17, 11040, Belgrade, Serbia
- 700 1_
- $a Nepovimova, Eugenie $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03, Hradec Kralove, Czech Republic
- 700 1_
- $a Kuča, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03, Hradec Kralove, Czech Republic; Biomedical Research Center, University Hospital Hradec Kralove, 50005, Hradec Kralove, Czech Republic
- 773 0_
- $w MED00002111 $t Chemico-biological interactions $x 1872-7786 $g Roč. 399 (20240709), s. 111138
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38992768 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111401 $b ABA008
- 999 __
- $a ok $b bmc $g 2201863 $s 1231250
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 399 $c - $d 111138 $e 20240709 $i 1872-7786 $m Chemico-biological interactions $n Chem Biol Interact $x MED00002111
- LZP __
- $a Pubmed-20241015